What does other research and development expense mean?

Costs associated with research and development activities that fall outside of primary project-specific allocations. This captures auxiliary R&D overhead, such as general laboratory supplies or non-project-specific scientific support.

OS Therapies OSTX Other Research And Development Expense

Other Research And Development Expense at other companies

CTO

Citius Oncology, Inc.CTOR

$469K-2.3%

Other financials

Income statement

See full

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

See full

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

See full

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

See full

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

See full

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:OtherResearchAndDevelopmentExpense.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's other research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OS Therapies's other research and development expense?: OS Therapies (OSTX) reported other research and development expense of $0 in Q1 2026.
What does other research and development expense mean?: Costs associated with research and development activities that fall outside of primary project-specific allocations. This captures auxiliary R&D overhead, such as general laboratory supplies or non-project-specific scientific support.